# NUVB (Nuvation Bio Inc.) - SEC EDGAR Financial Statements

> Nuvation Bio Inc. reported $201.7M in revenue and a net loss of $135.9M for the trailing twelve months ended September 30, 2026 (up 242.6% year over year), with a -61.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/NUVB
- Markdown: https://convexityos.com/fundamentals/NUVB.md
- SEC CIK: 0001811063
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:26 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001811063&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $201.7M | +242.6% YoY |
| Operating Income | TTM | -$123.4M | -61.2% margin |
| Net Income | TTM | -$135.9M | -67.4% net margin |
| Diluted EPS | TTM | -$386.33 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $663.4M | Total debt: $20.63M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $62.90M | $7.87M | $0 | -- | -- | -- |
| Cost of Revenue | -- | $7.08M | $0 | -- | -- | -- |
| **Gross Profit** | -- | $795K | $0 | -- | -- | -- |
| Research & Development | $115.1M | $99.12M | $71.29M | $87.81M | $69.04M | $32.60M |
| Selling, General & Admin | $151.6M | $69.23M | $28.53M | -- | -- | -- |
| Total Operating Expenses | $276.0M | $600.5M | $99.82M | $119.7M | $93.32M | $43.55M |
| **Operating Income** | -$213.1M | -$592.6M | -$99.82M | -$119.7M | -$93.32M | -$43.55M |
| **EBITDA** | -$211.3M | -$591.9M | -$99.60M | -$119.5M | -$93.13M | -$43.45M |
| Interest Income | $21.43M | $27.06M | $24.61M | $7.45M | $2.96M | $1.95M |
| Interest Expense | $13.68M | $341K | $0 | -- | -- | -- |
| Income Before Tax | -$204.6M | -$567.9M | -$75.80M | -$104.2M | -$86.85M | -$41.66M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$204.6M | -$567.9M | -$75.80M | -$104.2M | -$86.85M | -$41.66M |
| Basic EPS | -$0.60 | -$2.11 | -$0.35 | -$0.48 | -$0.44 | -$0.43 |
| **Diluted EPS** | -$0.60 | -$2.11 | -$0.35 | -$0.48 | -$0.44 | -$0.43 |
| Basic Shares Outstanding | 341.5K | 268.8K | 218.9K | 216.7K | 197.9K | 97.5M |
| Diluted Shares Outstanding | 341.5K | 268.8K | 218.9K | 216.7K | 197.9K | 97.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $44.95M | $31.69M | $83.23M | $41.87M | $13.12M | $4.83M | $3.08M | $5.71M |
| Cost of Revenue | -- | -- | -- | -- | $3.35M | $2.58M | $2.09M | $4.22M |
| **Gross Profit** | -- | -- | -- | -- | $9.77M | $2.26M | $990K | $1.50M |
| Research & Development | $32.68M | $30.66M | $35.05M | $34.30M | $28.85M | $27.36M | $24.60M | $29.30M |
| Selling, General & Admin | $42.55M | $42.59M | $38.31M | $40.33M | $37.36M | $38.48M | $35.39M | $26.14M |
| Total Operating Expenses | $87.16M | $82.72M | $79.35M | $75.90M | $69.55M | $68.42M | $62.09M | $62.52M |
| **Operating Income** | -$42.21M | -$51.04M | $3.88M | -$34.04M | -$56.43M | -$63.59M | -$59.00M | -$53.94M |
| **EBITDA** | -$41.63M | -$50.50M | $4.42M | -$33.50M | -$55.90M | -$63.23M | -$58.69M | -$53.72M |
| Interest Income | $6.16M | $4.60M | $5.11M | $5.30M | $6.03M | $4.78M | $5.32M | $6.06M |
| Interest Expense | $881K | $6.76M | $6.71M | $6.67M | $5.12M | $421K | $54K | $89K |
| Income Before Tax | -$41.90M | -$62.84M | $5.40M | -$36.59M | -$55.79M | -$59.01M | -$53.24M | -$49.45M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$41.90M | -$62.84M | $5.40M | -$36.59M | -$55.79M | -$59.01M | -$53.24M | -$49.45M |
| Basic EPS | -$0.12 | -$0.18 | $0.02 | -- | -$0.16 | -$0.17 | -$0.16 | -- |
| **Diluted EPS** | -$0.12 | -$0.18 | $0.01 | -- | -$0.16 | -$0.17 | -$0.16 | -- |
| Basic Shares Outstanding | 351.9K | 348.8K | 347.3K | -- | 342.4K | 340.7K | 338.6K | -- |
| Diluted Shares Outstanding | 351.9K | 348.8K | 377.5K | -- | 342.4K | 340.7K | 338.6K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $164.1M | $35.72M | $42.65M | $101.1M | $132.4M | $29.75M |
| Short-Term Investments | $365.1M | $467.0M | $568.6M | $559.9M | $633.0M | $186.0M |
| **Cash & Short-Term Investments** | $529.2M | $502.7M | $611.2M | $661.0M | $765.4M | $215.8M |
| Accounts Receivable, Net | $16.08M | $12.72M | $0 | -- | -- | -- |
| Inventory | $11.41M | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $571.5M | $526.3M | $616.4M | $667.3M | $772.1M | $220.7M |
| Property, Plant & Equipment, Net | $564K | $586K | $717K | $894K | $786K | $688K |
| Intangible Assets | $11.21M | $4.62M | $0 | -- | -- | -- |
| Other Non-Current Assets | $7.61M | $6.76M | $587K | $0 | -- | -- |
| **Total Non-Current Assets** | $23.30M | $14.37M | $5.05M | $4.82M | $4.08M | $1.11M |
| **Total Assets** | $594.8M | $540.6M | $621.5M | $672.1M | $776.2M | $221.8M |
| Accounts Payable | $9.48M | $6.35M | $2.21M | $2.14M | $3.92M | $2.17M |
| Short-Term Debt | $5.72M | $6.28M | $0 | -- | -- | -- |
| Deferred Revenue (Current) | $7.51M | $11.12M | $0 | -- | -- | -- |
| **Total Current Liabilities** | $82.23M | $58.24M | $13.97M | $13.16M | $16.93M | $6.55M |
| Deferred Revenue (Non-Current) | $145.8M | $15.57M | $0 | -- | -- | -- |
| **Total Non-Current Liabilities** | $206.9M | $18.59M | $2.39M | $3.90M | $13.23M | $157K |
| **Total Liabilities** | $289.1M | $76.84M | $16.36M | $17.07M | $30.15M | $6.71M |
| **Total Debt (incl. Leases)** | $10.15M | $8.91M | $4.01M | $4.26M | $3.06M | -- |
| Common Stock | $1.42B | $1.37B | $947.7M | $927.6M | $910.0M | $289.5M |
| Retained Earnings | -$1.12B | -$910.7M | -$342.8M | -$267.0M | -$162.8M | -$75.95M |
| Accumulated Other Comp. Income | -$187K | $573K | $181K | -$5.53M | -$1.19M | $1.56M |
| **Total Stockholders' Equity** | $305.7M | $463.8M | $605.1M | $655.1M | $746.0M | $215.1M |
| Total Equity | $305.7M | $463.8M | $605.1M | $655.1M | $746.0M | $215.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $153.8M | $258.6M | $125.4M | $164.1M | $98.90M | $248.0M | $47.98M | $35.72M |
| Short-Term Investments | $509.6M | $402.4M | $408.3M | $365.1M | $450.1M | $359.8M | $413.7M | $467.0M |
| **Cash & Short-Term Investments** | $663.4M | $661.0M | $533.7M | $529.2M | $549.0M | $607.7M | $461.7M | $502.7M |
| Accounts Receivable, Net | $36.55M | $27.83M | $22.72M | $16.08M | $8.32M | $2.69M | $409K | $12.72M |
| Inventory | $15.34M | $19.90M | $15.84M | $11.41M | $5.71M | $552K | $14K | $0 |
| **Total Current Assets** | $734.7M | $726.4M | $591.5M | $571.5M | $577.5M | $623.2M | $475.6M | $526.3M |
| Property, Plant & Equipment, Net | $2.22M | $715K | $535K | $564K | $560K | $615K | $562K | $586K |
| Intangible Assets | $19.80M | $10.29M | $10.76M | $11.21M | $11.68M | $12.14M | $4.41M | $4.62M |
| Other Non-Current Assets | $7.52M | $3.82M | $3.82M | $7.61M | $7.46M | $6.62M | $6.62M | $6.76M |
| **Total Non-Current Assets** | $43.73M | $18.07M | $18.71M | $23.30M | $24.03M | $24.02M | $16.92M | $14.37M |
| **Total Assets** | $778.4M | $744.5M | $610.2M | $594.8M | $601.6M | $647.2M | $492.5M | $540.6M |
| Accounts Payable | $9.45M | $12.09M | $22.43M | $9.48M | $15.36M | $22.42M | $10.54M | $6.35M |
| Short-Term Debt | $5.97M | $5.89M | $5.79M | $5.72M | $5.62M | $5.58M | $5.68M | $6.28M |
| Deferred Revenue (Current) | $9.06M | $8.86M | $8.65M | $7.51M | $6.72M | $9.72M | $10.77M | $11.12M |
| **Total Current Liabilities** | $98.56M | $86.75M | $79.52M | $82.23M | $68.13M | $66.36M | $52.77M | $58.24M |
| Deferred Revenue (Non-Current) | $151.5M | $151.1M | $151.9M | $145.8M | $144.6M | $142.8M | $13.61M | $15.57M |
| **Total Non-Current Liabilities** | $451.9M | $403.9M | $211.2M | $206.9M | $207.5M | $208.0M | $20.26M | $18.59M |
| **Total Liabilities** | $550.4M | $490.6M | $290.7M | $289.1M | $275.7M | $274.3M | $73.03M | $76.84M |
| **Total Debt (incl. Leases)** | $20.63M | $9.52M | $9.83M | $10.15M | $10.46M | $10.79M | $11.41M | $8.91M |
| Common Stock | $1.45B | $1.43B | $1.43B | $1.42B | $1.40B | $1.40B | $1.38B | $1.37B |
| Retained Earnings | -$1.21B | -$1.17B | -$1.11B | -$1.12B | -$1.08B | -$1.02B | -$964.0M | -$910.7M |
| Accumulated Other Comp. Income | -$4.62M | -$2.61M | -$1.68M | -$187K | -$139K | -$327K | $545K | $573K |
| **Total Stockholders' Equity** | $228.0M | $253.9M | $319.6M | $305.7M | $325.9M | $372.9M | $419.5M | $463.8M |
| Total Equity | $228.0M | $253.9M | $319.6M | $305.7M | $325.9M | $372.9M | $419.5M | $463.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$204.6M | -$567.9M | -$75.80M | -$104.2M | -$86.85M | -$41.66M |
| Depreciation & Amortization | $1.74M | $683K | $222K | $199K | $184K | $103K |
| Stock-Based Compensation | $35.89M | $32.27M | $19.51M | $16.29M | $9.27M | $2.20M |
| Change in Receivables | -$3.35M | -$12.72M | $0 | -- | -- | -- |
| Change in Payables | $3.13M | -$1.65M | $70K | -$1.79M | $1.86M | $34K |
| **Operating Cash Flow** | -$173.4M | -$130.4M | -$68.00M | -$96.11M | -$68.19M | -$36.53M |
| Purchases of Investments | -$354.4M | -$339.6M | -$703.4M | -$520.3M | -$609.3M | -$143.3M |
| **Investing Cash Flow** | $99.52M | $122.7M | $8.92M | $63.46M | -$454.7M | -$70.32M |
| **Financing Cash Flow** | $202.5M | $331K | $628K | $1.33M | $625.5M | $133.1M |
| **Net Change in Cash** | $128.4M | -$6.93M | -$58.45M | -$31.32M | $102.7M | $26.29M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$41.90M | -$62.84M | $5.40M | -$36.59M | -$55.79M | -$59.01M | -$53.24M | -$49.45M |
| Depreciation & Amortization | $578K | $536K | $536K | $539K | $534K | $356K | $310K | $219K |
| Stock-Based Compensation | $10.07M | $10.46M | $9.03M | $7.99M | $8.02M | $12.03M | $7.85M | $10.19M |
| Change in Receivables | -$8.72M | -$5.10M | -$6.65M | -$7.75M | -$5.63M | -$2.28M | $12.31M | -$12.61M |
| Change in Payables | -$2.64M | -$9.85M | $12.96M | -$5.88M | -$7.06M | $11.88M | $4.19M | -$6.03M |
| **Operating Cash Flow** | -$38.56M | -$42.97M | $5.07M | -$29.73M | -$52.89M | -$48.18M | -$42.63M | -$46.30M |
| Purchases of Investments | -$225.9M | -$67.69M | -$82.15M | -$44.90M | -$167.1M | -$81.67M | -$60.71M | -$32.04M |
| **Investing Cash Flow** | -$109.3M | $5.99M | -$43.64M | $87.08M | -$96.62M | $54.88M | $54.18M | $51.77M |
| **Financing Cash Flow** | $43.16M | $170.5M | $44K | $8.06M | $501K | $193.4M | $548K | -$900K |
| **Net Change in Cash** | -$104.8M | $133.2M | -$38.70M | $65.19M | -$149.1M | $200.0M | $12.25M | $5.69M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 10.1% | -- | -- | -- | -- |
| **Operating Margin** | -338.7% | -7527.3% | -- | -- | -- | -- |
| **Net Profit Margin** | -325.3% | -7213.8% | -- | -- | -- | -- |
| Return on Equity (ROE) | -66.9% | -122.5% | -12.5% | -15.9% | -11.6% | -19.4% |
| Return on Assets (ROA) | -34.4% | -105.1% | -12.2% | -15.5% | -11.2% | -18.8% |
| Current Ratio | 6.95x | 9.04x | 44.11x | 50.70x | 45.62x | 33.69x |
| Quick Ratio | 6.81x | 9.04x | 43.74x | 50.23x | 45.22x | 32.93x |
| Debt to Equity | 0.03x | 0.02x | 0.01x | 0.01x | 0.00x | -- |
| **Revenue Growth (YoY)** | +699.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | 54.3% | 27.5% | 16.3% | 10.1% |
| **Operating Margin** | -61.2% | -81.0% | -105.0% | -338.7% | -871.0% | -1564.9% | -5762.8% | -7527.3% |
| **Net Profit Margin** | -67.4% | -88.2% | -102.1% | -325.3% | -813.1% | -1413.4% | -5534.2% | -7213.8% |
| Return on Equity (ROE) | -59.6% | -59.0% | -45.7% | -66.9% | -66.7% | -54.4% | -144.6% | -122.5% |
| Return on Assets (ROA) | -17.5% | -20.1% | -23.9% | -34.4% | -36.2% | -31.3% | -123.1% | -105.1% |
| Current Ratio | 7.45x | 8.37x | 7.44x | 6.95x | 8.48x | 9.39x | 9.01x | 9.04x |
| Quick Ratio | 7.30x | 8.14x | 7.24x | 6.81x | 8.39x | 9.38x | 9.01x | 9.04x |
| Debt to Equity | 0.09x | 0.04x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.02x |
| **Revenue Growth (YoY)** | +242.6% | +555.6% | +2598.7% | +633.1% | +1704.7% | +236.8% | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | +2464.8% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
